Facephi Biometria SA AI Stock Analysis
Want to see ES:FACE full AI Analyst Report?
Facephi Biometria SA (FACE) AI Stock Analysis
Facephi Biometria SA
(BME:FACE)
The overall score of 53 reflects a company with improving but still weak financial fundamentals, weighed down heavily by an extreme valuation. The primary risk is the P/E ratio of 173, which prices in perfection and leaves no room for error. While the balance sheet is solid and revenue is growing, the lack of meaningful profitability and negative free cash flow do not justify the current premium. Technical trends are neutral, offering no counterbalance to the fundamental and valuation concerns.
Facephi Biometria SA (FACE) vs. iShares MSCI Spain ETF (EWP)
- Market Cap
- EUR 48.41M
- Dividend Yield
- ―
- Average Volume (3M)
- 24.00K
- Price to Earnings (P/E)
- -91.5
- Beta (1Y)
- -0.02
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Spain
- Employees
- 256
- Sector
- General
- Sector Strength
- 55
- Industry
- Software - Application
Facephi Biometria SA Business Overview & Revenue Model
Company Description
Facephi Biometria, S.A. delivers advanced biometric facial recognition technology solutions, primarily targeting the banking industry across Latin America, the United States, Asia, and other international markets. The company's offerings include "Fac...
How the Company Makes Money
Facephi makes money by providing biometric and digital-identity software to organizations that need to verify users remotely and authenticate them securely. Its revenue model is centered on selling access to its technology (software and related servi...
Facephi Biometria SA Financial Statement Overview
Summary
Financial performance is mixed. Revenue growth of 20.7% and a return to net profitability are positive, supported by a conservatively leveraged balance sheet (D/E 0.33). However, net margin is razor-thin at 1.0%, ROE is low at 1.7%, and free cash flow is negative due to heavy capex, indicating the company is still in a rebuilding phase.
Income Statement
54NeutralBalance Sheet
70PositiveCash Flow
55Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.32M | 35.98M | 28.88M | 29.32M | 22.28M | 13.16M |
| Gross Profit | 8.23M | 22.75M | 13.21M | 25.90M | 22.92M | 13.46M |
| EBITDA | 1.85M | 7.90M | -220.15K | -648.04K | 3.30M | 821.13K |
| Net Income | -477.20K | 368.70K | -8.88M | -4.31M | 1.11M | -553.90K |
Balance Sheet | ||||||
| Total Assets | 39.00M | 48.01M | 49.71M | 45.71M | 32.25M | 18.36M |
| Cash, Cash Equivalents and Short-Term Investments | 838.40K | 2.21M | 5.70M | 2.90M | 2.05M | 1.39M |
| Total Debt | 8.08M | 7.20M | 10.18M | 12.96M | 7.83M | 6.22M |
| Total Liabilities | 23.61M | 26.22M | 30.52M | 25.67M | 17.04M | 9.65M |
| Stockholders Equity | 14.98M | 21.79M | 19.19M | 20.04M | 15.21M | 8.71M |
Cash Flow | ||||||
| Free Cash Flow | -221.86K | -1.42M | -4.53M | -664.63K | -7.88M | -6.15M |
| Operating Cash Flow | 8.52M | 7.34M | 724.43K | 853.21K | -5.82M | -3.60M |
| Investing Cash Flow | -8.07M | -8.76M | -5.28M | -9.83M | -2.20M | -2.14M |
| Financing Cash Flow | -1.14M | -919.49K | 7.56M | 9.54M | 8.60M | 1.30M |
Facephi Biometria SA Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ES:FACE, the sentiment is Positive. The current price of 1.83 is above the 20-day moving average (MA) of 1.78, above the 50-day MA of 1.70, and below the 200-day MA of 1.99, indicating a neutral trend. The MACD of 0.02 indicates Negative momentum. The RSI at 55.24 is Neutral, neither overbought nor oversold. The STOCH value of 86.16 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for ES:FACE.
Facephi Biometria SA Peers Comparison
Overall Rating
ES:SAI69Neutral
ES:IZER53Neutral
ES:FACE53Neutral
ES:AI44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | EUR 24.38M | -0.49 | -18.39% | ― | -1.95% | -200.12% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | EUR 254.49M | 105.03 | 1.68% | ― | 25.36% | -66.56% | |
| 53Neutral | EUR 48.41M | -91.50 | 1.92% | ― | ― | ― | |
| 44Neutral | EUR 125.56M | -7.64 | -28.40% | ― | -16.99% | -250.00% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ES:FACE | Facephi Biometria SA | 1.83 | -0.79 | -30.15% | |
| ES:IZER | Izertis SA | 7.16 | -2.28 | -24.15% | |
| ES:SAI | Substrate Artificial Intelligence SA | 0.03 | -0.06 | -64.84% | |
| ES:AI | Airtificial Intelligence Structures SA | 0.08 | -0.02 | -21.57% | |
| ES:SCO | Seresco SA | 5.40 | -1.19 | -18.03% | |
| ES:ATSI | Aplicaciones y Tratamiento de Sistemas, S.A. | 3.52 | -0.96 | -21.43% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026
